Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5067399 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL14156075 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL14488913 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine SCHEMBL35551 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL14488843 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine SCHEMBL23646852 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL12533535 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL19766264 | 1.00 | TTR (0.38) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| Icosahydrodibenzo[B,K][1,4,7,10,13,16]Hexaoxacyclooctadecine SCHEMBL9770208 | 0.94 | TTR (0.33) | TTRALDH1A1PDK1CHRM2CHRM4 | |
| SCHEMBL10919024 | 0.92 | ALDH1A1 (0.42) | TTRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260142234-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | ENEVATE CORP (US) | 2026-05-21 | — | — | US | claimed |
| US-12438190-B2 | Silicon-based energy storage devices with electrolyte containing crown ether based compounds | ENEVATE CORPORATION (US) | 2025-10-07 | — | — | US | claimed |
| US-11923545-B2 | Crown ethers as additives for silicon-based Li-ion batteries | ENEVATE CORPORATION (US) | 2024-03-05 | — | — | US | claimed |
| US-20210226251-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | ENEVATE CORPORATION | 2021-07-22 | — | — | US | claimed |
| US-20260142234-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | ENEVATE CORP (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4673579-A1 | SYSTEM AND METHOD FOR FRACTIONAL ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES | NORTHSTAR MEDICAL TECHNOLOGIES, LLC (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12438190-B2 | Silicon-based energy storage devices with electrolyte containing crown ether based compounds | ENEVATE CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20240304352-A1 | System and Method For Fractional Elution of Mother-Daughter Radionuclides | NorthStar Medical Technologies, LLC (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024182027-A1 | SYSTEM AND METHOD FOR FRACTIONAL ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES | NorthStar Medical Technologies, LLC (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240239686-A1 | METHOD FOR STACKED ELUTION OF MOTHER-DAUGHTER RADIONUCLIDES | NorthStar Medical Technologies, LLC (US) | 2024-07-18 | — | — | US | disclosed |
| US-11923545-B2 | Crown ethers as additives for silicon-based Li-ion batteries | ENEVATE CORPORATION (US) | 2024-03-05 | — | — | US | disclosed |
| US-20220393174-A1 | CROWN ETHERS AS ADDITIVES FOR SILICON-BASED LI-ION BATTERIES | ENEVATE CORPORATION | 2022-12-08 | — | — | US | disclosed |
| US-20220393174-A1 | CROWN ETHERS AS ADDITIVES FOR SILICON-BASED LI-ION BATTERIES | ENEVATE CORPORATION | 2022-12-08 | — | — | US | disclosed |
| US-20210226251-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | ENEVATE CORPORATION | 2021-07-22 | — | — | US | disclosed |
| US-20210226251-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | ENEVATE CORPORATION | 2021-07-22 | — | — | US | disclosed |
| US-7348115-B2 | Electrophotographic photoconductor, process cartridge, image forming apparatus and image forming method | RICOH COMPANY, LTD. (JP) | 2008-03-25 | — | — | US | disclosed |
| US-20050170271-A1 | Electrophotographic photoconductor, process cartridge, image forming apparatus and image forming method | YAMANAMI HIROFUMI (JP) | 2005-08-04 | — | — | US | disclosed |
| EP-1324139-A2 | Electrophotographic photoconductor, process cartridge, image forming apparatus and image forming method | Ricoh Company, Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-4600771-A | Process for the preparation of acylated sugars with a glycosidically bonded isothiocyanate group | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260142234-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CROWN ETHER BASED COMPOUNDS | SLC8A1, RPS4X, LBR | TTR 3833/4885ALDH1A1 3457/4885PDK1 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.